Home/Actipulse Neuroscience/Adrien Chatillon
AC

Adrien Chatillon

Investor Relations Contact

Actipulse Neuroscience

Actipulse Neuroscience Pipeline

DrugIndicationPhase
Major Depressive Disorder ProgramMajor Depressive Disorder (MDD)Phase 3
Drug Delivery ProgramNot Specified (Platform Enhancement)Pre-clinical
Oncology 1Not Specified (Oncology)Pre-clinical
CNC2Central Nervous System ConditionPlanned
CNC3Central Nervous System ConditionPlanned
CNC4Central Nervous System ConditionPlanned